High-performance Countercurrent Chromatography to Access Rhodiola rosea Influenza Virus Inhibiting Constituents
- 11 August 2020
- journal article
- research article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 87 (10/11), 818-826
- https://doi.org/10.1055/a-1228-8473
Abstract
Dedicated to Professor Arnold Vlietinck on the occasion of his 80th birthday. In a cytopathic effect inhibition assay, a standardized Rhodiola rosea root and rhizome extract, also known as roseroot extract (SHR-5), exerted distinct anti-influenza A virus activity against HK/68 (H3N2) (IC50 of 2.8 µg/mL) without being cytotoxic. For fast and efficient isolation and identification of the extractʼs bioactive constituents, a high-performance countercurrent chromatographic separation method was developed. It resulted in a three-stage gradient elution program using a mobile phase solvent system composed of ethyl acetate/n-butanol/water (1 : 4 : 5 → 2 : 3 : 5 → 3 : 2 : 5) in the reversed-phase mode. The elaborated high-performance countercurrent chromatographic method allowed for fractionation of the complex roseroot extract in a single chromatographic step in a way that only one additional orthogonal isolation/purification step per fraction yielded 12 isolated constituents. They cover a broad polarity range and belong to different structural classes, namely, the phenylethanoid tyrosol and its glucoside salidroside, the cinnamyl alcohol glycosides rosavin, rosarin, and rosin as well as gallic acid, the cyanogenic glucoside lotaustralin, the monoterpene glucosides rosiridin and kenposide A, and the flavonoids tricin, tricin-5-O-β-D-glucopyranoside, and rhodiosin. The most promising anti-influenza activities were determined for rhodiosin, tricin, and tricin-5-O-β-D-glucopyranoside with IC50 values of 7.9, 13, and 15 µM, respectively. The herein established high-performance countercurrent chromatographic protocol enables fast and scalable access to major as well as minor roseroot constituents. This is of particular relevance for extract standardization, quality control, and further in-depth pharmacological investigations of the metabolites of this popular traditional herbal remedy. Received: 12 June 2020 Accepted after revision: 22 July 2020 Publication Date: 11 August 2020 (online) Georg Thieme Verlag KG Stuttgart · New YorkKeywords
Funding Information
- Wilhelm Doerenkamp-Foundation, Chur, Switzerland (Natvantage grant (2018))
This publication has 44 references indexed in Scilit:
- Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry InhibitorViruses, 2018
- Rhodiola rosea L.: an Herb with Anti-Stress, Anti-Aging, and Immunostimulating Properties for Cancer ChemopreventionCurrent Pharmacology Reports, 2017
- The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune functionBMC Complementary and Alternative Medicine, 2017
- Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factorsArchiv für die gesamte Virusforschung, 2016
- Extension of Drosophila Lifespan by Rhodiola rosea through a Mechanism Independent from Dietary RestrictionPLOS ONE, 2013
- Regulation of Medicinal Plants for Public Health - European Community Monographs on Herbal SubstancesPlanta Medica, 2012
- Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacyPhytomedicine, 2010
- Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activitiesBioorganic & Medicinal Chemistry, 2009
- The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3Phytomedicine, 2009
- Rhodiola: A Promising Anti-Aging Chinese HerbRejuvenation Research, 2007